05/13/2024
3:57 PM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
3:39 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
4:59 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024
3:16 PM | Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
04/26/2024
4:23 PM | Aerovate Therapeutics (Filer)
| Form ARS | |
04/26/2024
6:18 AM | Aerovate Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
6:19 AM | Aerovate Therapeutics (Filer)
| Form DEFA14A | |
|
04/19/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:35 PM | Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:35 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
3:25 PM | Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/12/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
5:42 PM | Aerovate Therapeutics (Subject)
Atlas Venture Associates XII, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
6:18 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
6:24 PM | Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
5:31 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
8:22 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:15 PM | Aerovate Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/25/2024
3:12 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:35 PM | Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:37 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
2:28 PM | Aerovate Therapeutics (Subject)
Eldridge George A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:34 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
6:09 PM | Aerovate Therapeutics (Subject)
Sofinnova Venture Partners X, L.P. (Filed by)
| Form SC 13D/A | |
America’s worst nightmare? (Ad) What This Group Has Planned for the 2024 Election Will Shock You
Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late. Click here to watch this bombshell exposé now. |
02/20/2024
5:38 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
3:28 PM | Aerovate Therapeutics (Subject)
TCG Crossover GP I, LLC (Filed by)
| Form SC 13G | |
02/07/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:45 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Pigot Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:29 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:11 PM | Aerovate Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/08/2024
6:59 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
3:17 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:00 PM | Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
4:50 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:24 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
3:10 PM | Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/07/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
7:04 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
3:13 PM | Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
3:17 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2023
3:46 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
7:16 AM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023
7:03 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
4:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
4:00 PM | Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
1:05 PM | Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
7:10 AM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
7:16 AM | Aerovate Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
10:53 AM | Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2023
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
5:00 PM | Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
4:24 PM | Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2023
4:03 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
America’s worst nightmare? (Ad) What This Group Has Planned for the 2024 Election Will Shock You
Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late. Click here to watch this bombshell exposé now. |
07/11/2023
4:04 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/11/2023
4:06 PM | Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
5:00 PM | Aerovate Therapeutics (Issuer)
NIVEN RALPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
2:35 PM | Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/05/2023
6:55 PM | Aerovate Therapeutics (Subject)
NIVEN RALPH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2023
1:22 PM | Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2023
4:14 PM | Aerovate Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
5:00 PM | Aerovate Therapeutics (Issuer)
Dorval Allison (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
